CGEN News
Compugen to Present UnigenX Platform at the 18th Annual PEGS Europe Summit
Compugen to Present UnigenX Platform at the 18th Annual PEGS Europe Summit Compugen to Present UnigenX Platform at the 18th Annual PEGS Europe SummitPR NewswireHOLON, Israel, Nov. 10, 2026 HOLON, Israel, Nov. 10, 2026 /PRNewswire/ --Compugen Ltd.(Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer...
PR Newswire
Compugen to Present UnigenX Platform at the 18th Annual PEGS Europe Summit
Compugen to Present UnigenX Platform at the 18th Annual PEGS Europe Summit Compugen to Present UnigenX Platform at the 18th Annual PEGS Europe SummitPR NewswireHOLON, Israel, Nov. 10, 2026 HOLON, Israel, Nov. 10, 2026 /PRNewswire/ --Compugen Ltd.(Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer...
PR Newswire
Compugen (CGEN) delivered earnings and revenue surprises of +25.00% and +41.52%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Compugen Reports Third Quarter 2026 Results Compugen Reports Third Quarter 2026 ResultsPR NewswireHOLON, Israel, Nov. 9, 2026 MAIA-ovarian fully enrolled; results expected by end of Q1 2027Phase 3 rilvegostomig high-level results from partner AstraZeneca anticipated in H2 2027 from...
PR Newswire
Dentsply (XRAY) delivered earnings and revenue surprises of -3.33% and -2.34%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Nuvation Bio (NUVB) delivered earnings and revenue surprises of -9.09% and +32.33%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Compugen to Participate in November Investor Conferences Compugen to Participate in November Investor ConferencesPR NewswireHOLON, Israel, Nov. 3, 2026 HOLON, Israel, Nov. 3, 2026 /PRNewswire/ --Compugen Ltd.(NASDAQ: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in...
PR Newswire
BioMarin (BMRN) delivered earnings and revenue surprises of +355.56% and -0.23%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Compugen to Release Third Quarter 2026 Results on Monday, November 9, 2026 Compugen to Release Third Quarter 2026 Results on Monday, November 9, 2026PR NewswireHOLON, Israel, Oct. 26, 2026 HOLON, Israel, Oct. 26, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage...
PR Newswire
Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development Conference Compugen to Participate in a Fireside Chat at the H.C. Wainwright 3rd Annual AI Based Drug Discovery & Development ConferencePR NewswireHOLON, ISRAEL, Oct. 6, 2026HOLON...
PR Newswire
Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen Platform Update on October 5, 2026 Compugen to Host Virtual KOL Event on COM701 in Ovarian Cancer & Unigen Platform Update on October 5, 2026PR NewswireHOLON, Israel, Sept. 22, 2026 HOLON, Israel, Sept. 22, 2026 /PRNewswire...
PR Newswire